Clinical Trial

Remote Ischemic Conditioning Plus Stenting for Symptomatic Carotid Artery Stenosis

Study acronym: RICSICAS
Recruiting
View on ClinicalTrials.gov →
Summary
Remote ischemic conditioning (RIC) has emerged as a promising non-invasive strategy to protect the brain, with evidence suggesting its benefit in patients with carotid artery stenting (CAS). However, the long-term benefit and safety of chronic RIC in this population remain unknown. This trial aims to evaluate whether chronic RIC reduces the incidence of major vascular events and improves clinical outcomes in high-risk patients with carotid artery stenosis who received CAS.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2026-02-09; most recent amendment 2026-03-30.
Status change: Not Yet Recruiting → Recruiting 2026-03-05
Trial Details
NCT Number NCT07412249
Lead Sponsor General Hospital of Shenyang Military Region
Conditions Carotid Stenosis
Enrollment 300 participants
Start Date 2026-03-04
Primary Completion 2027-11-30 (estimated)
Study Completion 2027-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-03